ASK1 regulates the survival of neuroblastoma cells by interacting with TLX and stabilizing HIF-1α

Cell Signal. 2017 Jan:30:104-117. doi: 10.1016/j.cellsig.2016.11.018. Epub 2016 Nov 24.

Abstract

Elevated expression of TLX (also called as NR2E1) in neuroblastoma (NB) correlates with unfavorable prognosis, and TLX is required for self-renewal of NB cells. Knockdown of TLX has been shown to reduce the NB sphere-forming ability. ASK1 (MAP3K5) and TLX expression are both enhanced in SP (side population) NB and patient-derived primary NB sphere cell lines, but the majority of non-SP NB lines express lower ASK1 expression. We found that ASK1 phosphorylated and stabilized TLX, which led induction of HIF-1α, and its downstream VEGF-A in an Akt dependent manner. In depleting ASK1 upon hypoxia, TLX decreased and the apoptosis ratio of NB cells was enhanced, while low-ASK1-expressing NB cell lines were refractory in TUNEL assay by using flow cytometry. Interestingly, primary NB spheres cell lines express only high levels of active pASK1Thr-838 but the established cell lines expressed inhibitory pASK1Ser-966, and both could be targeted by ASK1 depletion. We report a novel pro-survival role of ASK1 in the tumorigenic NB cell populations, which may be applied as a therapeutic target, inducing apoptosis specifically in cancer stem cells.

Keywords: ASK1; Apoptosis; HIF-1α; Neuroblastoma; TLX.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Benzimidazoles / metabolism
  • Carbocyanines / metabolism
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Gene Silencing / drug effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • MAP Kinase Kinase Kinase 5 / chemistry
  • MAP Kinase Kinase Kinase 5 / metabolism*
  • Membrane Potential, Mitochondrial / drug effects
  • Mice, SCID
  • Neuroblastoma / metabolism*
  • Neuroblastoma / pathology*
  • Orphan Nuclear Receptors
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Domains
  • Protein Kinase Inhibitors / pharmacology
  • Protein Stability / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Up-Regulation / drug effects
  • Xenograft Model Antitumor Assays

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Benzimidazoles
  • Carbocyanines
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • NR2E1 protein, human
  • Orphan Nuclear Receptors
  • Protein Kinase Inhibitors
  • Receptors, Cytoplasmic and Nuclear
  • endothelial PAS domain-containing protein 1
  • 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine
  • Proto-Oncogene Proteins c-akt
  • MAP Kinase Kinase Kinase 5
  • MAP3K5 protein, human